Friday, December 12, 2014

Important Read! Slides Now Available for FDLI and UMD discuss DQSA in 2 days! See What David Miller of IACP has to Say Such as " No evidence of any enforcement of DQSA for prescribers."

8:45 – 10:00 AM
503A Traditional Pharmacy Compounding / Slides
Lee Rosebush, JD, Counsel, BakerHostetler
David Miller, RPh, Executive Vice President, IACP
Caroline D. Juran, RPh, Executive Director, Virginia Board of Pharmacy

Moderated by Frank Palumbo, PhD, JD, Executive Director & Professor, Center on Drugs and Public Policy, UM School of Pharmacy

-

1 comment:

Anonymous said...

At least in this set, the presentations are silent on the amendment to Misbranded Drugs Section 502 (21 USC 352) under Sec 103 Penalties "(bb)( If the advertising or promotion of a compounded drug is false or misleading in any particular."

December 12, 2014 at 11:24 AM

Post a Comment

Subscribe to: Post Comments (Atom)